Partnering with 7thirty Capital, Israel based OurCrowd is set to launch $30 million fund to invest in cannabis tech. Set to be based in Boulder, Colorado, USA, the newly established fund will focus on emerging cannabis technology companies in med-tech, ag-tech, retail, e-commerce and marketplaces.
The fund is set to be active globally and will include countries such as Israel, Canada and the United States of America.
Micah Tapman is leading the 7thirty Capital which is an early- stage cannabis technology investor.
According to OurCrowd CEO Jon Medved:
“The amount of serious medical research in cannabis is booming. This market will generate unprecedented global investment activity and returns for cannabis focused startups.”
Founded in 2012, OurCrowd is a venture capital firm specializing in early stage, seed stage companies, growth capital companies, pre-A, series A and B investments and start-ups. Headquartered in the Israel, OurCrowd invests in the transportation tech, greentech, enterprise solutions, telecommunications, webtech, fintech, medtech, consumer, cybersecurity, artificial intelligence and machine learning, the internet of things, 3D printing, digitally enabled precision agriculture, autonomous robotics, blockchain technology, and AR/VR sector.
About 7thirty Capital
Headquartered in the US, 7thirty Capital is a principal investment firm specializing in debt or equity investments. 7thirty Capital also seeks to invest in the legal cannabis industry with a focus on the emerging Cannabidiol (CBD) market for functional foods and beverages, machine learning, supply chain, data & analytics, marketplaces, retail tech, payment solutions, AG tech and platforms.